Home Biotechnology Industry News Prominent Diagnostics Executive, Douglas W. Berg, Appointed to RPS…

Prominent Diagnostics Executive, Douglas W. Berg, Appointed to RPS…

Rapid Pathogen Screening, Inc. (RPS®), an emerging leader in point-of-care diagnostic testing, today announced that Douglas W. Berg has been appointed to its Board of Directors, effective...

(PRWeb April 20, 2012)

Read the full story at http://www.prweb.com/releases/2012/4/prweb9423127.htm